Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

NRG - NRG-GU010 - (GUIDANCE)

Study Phase: Phase III - Radiation Therapy + Drug

Condition(s): Intermediate risk prostate cancer
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation

ClinicalTrials.gov NCT ID: NCT05050084

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_helen-mcgunnigle

Helen McGunnigle

Primary Contact - Study Coordinator

484-658-5044
helen.mcgunnigle@sluhn.org

profile_william-smith

William H. Smith, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today